By: Victor The Bittensor ecosystem continues to accelerate across infrastructure, products, and adoption. From record-breaking trading volumes to new subnets and institutional moves, here are the biggest highlights from last week. ⚙️ SUBNET UPDATES & […]
SUMMARY: Travis breaks down Bittensor’s Yuma consensus — a mechanism where validators are rewarded for aligning with the network’s collective judgment — and explains why it’s the foundation of Bittensor’s integrity. Beyond powering decentralized AI, […]
Bittensor community figure Keith Singery has released a 20-minute video passionately championing Ridges AI (Subnet 62) — a decentralized coding platform that he describes as one of the most powerful engines of innovation in open-source […]
Taoillium has once again pushed the boundaries of combining AI potential with decentralization. The group has launched Image-to-Image, a feature that enables users to transform any image into something new using the potential of AI. […]
Contributor: School of Crypto The herd is coming. Chamath Palihapitiya is talking about Bittensor. His partner on the popular All-In podcast Jason Calacanis joined a Bittensor investment fund called Stillcore Capital with Mark Jeffrey and […]
Contributor: LadyofTAO October 9, 2025 — Yuma, a subsidiary of Digital Currency Group (DCG) and a core contributor to the Bittensor decentralized AI network, has launched Yuma Asset Management, a new division supported by a […]
SUMMARY: The video compares Bittensor ($TAO) and Render ($RNDR), two leading AI-focused crypto projects, analyzing their use cases, teams, and tokenomics. While Render enables decentralized GPU rendering for creators, Bittensor rewards contributors who provide intelligence […]
SUMMARY: The video explores xTAO’s approach to cryptocurrency treasury management, detailing how it balances volatility, operational efficiency, and tax advantages through its TSXV listing and Cayman Islands base. It highlights xTAO’s transparent capital structure, staking-based […]
Bringing a new drug to market is notoriously slow and expensive. Recent analyses estimate that the median cost — including failures — sits around $985 million, while the average exceeds $1.3 billion per approved drug. […]
As Bittensor grows, a question has become increasingly loud: which subnets are genuinely sustainable? TAO Revenue renders that answer fact-based instead of speculative. TAO Revenue is live, a fresh new dashboard tracking inflows, outflows, and […]
© Copyright 2026 The TAO Daily